Long-lasting synaptic loss after repeated induction of LTD: independence to the means of LTD induction.
Short- and long-lasting synaptic plasticity is assumed to be the cellular basis of short- and long-lasting memory, respectively. However, the cellular consequences leading to the long-lasting synaptic plasticity, assumed to include the processes of synapse formation and elimination, remain unknown. Using hippocampal slices maintained stably in culture, we found previously that the repeated induction of long-term potentiation (LTP) triggered a slowly developing long-lasting enhancement in synaptic transmission strength accompanied by synapse formation, which was separate from LTP itself. We recently reported a phenomenon apparently of a mirror-image effect. The repeated activations of metabotropic glutamate receptor (mGluR), which induces long-term depression (LTD), triggered a long-lasting reduction in synaptic strength accompanied by synapse elimination. To clarify whether the reported long-lasting effect was specific to the drugs used previously and whether the effect was specific to mGluR-mediated LTD, we exposed the cultured slices repeatedly to another Group I metabotropic glutamate receptor (mGluR) agonist, an N-methyl-d-aspartate receptor agonist, and a Na+/K+-pump inhibitor. All these treatments resulted in an equivalent long-lasting synaptic reduction/elimination when repeated three times, indicating that the repeated LTD induction leads to synapse elimination. The independence of synapse elimination to the means of LTD induction suggests that the signals leading to short-term plasticity and long-term plasticity are independent. Detailed inspections in the representative case of mGluR activation revealed that the reduction in synaptic strength developed with a approximately 1-week delay from the decrease in the number of synaptic structures. This synapse elimination should be unique as it is activity-dependent rather than inactivity-dependent.
Kamikubo
Yuji
Y
Laboratory of Synaptic Plasticity, Osaka University Graduate School of Frontier Biosciences, Machikaneyama-cho 1-1, Toyonaka, Osaka 560-0043 Japan.
Egashira
Yoshihiro
Y
Tanaka
Tsunehiro
T
Shinoda
Yo
Y
Tominaga-Yoshino
Keiko
K
Ogura
Akihiko
A
D000818:Animals; D000831:Animals, Newborn; D004305:Dose-Response Relationship, Drug; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D006624:Hippocampus / Q000166:cytology; D007150:Immunohistochemistry / Q000379:methods; D066298:In Vitro Techniques; D036881:Long-Term Synaptic Depression / Q000187:drug effects / Q000502:physiology*; D008734:Methoxyhydroxyphenylglycol / Q000031:analogs & derivatives / Q000494:pharmacology; D046529:Microscopy, Electron, Transmission / Q000379:methods; D016202:N-Methylaspartate / Q000494:pharmacology; D009474:Neurons / Q000502:physiology* / Q000528:radiation effects; D009828:Oleanolic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013569:Synapses / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D016708:Synaptophysin / Q000378:metabolism
C488648:3alpha,25-dihydroxyolean-12-en-28-oic acid; D018690:Excitatory Amino Acid Agonists; D016708:Synaptophysin; D008734:Methoxyhydroxyphenylglycol; D016202:N-Methylaspartate; D009828:Oleanolic Acid; C010117:3,4-dihydroxyphenylglycol